SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Net sales declined -26.81%  to  Rs. 221.60 million from Rs. 302.77 millions.The Net Loss for the quarter ended September 2024 is Rs. -49.95 millions as compared to Net Loss of Rs. -195.60 millions of corresponding quarter ended September 2023 Operating profit Margin for the quarter ended September 2024 improved to -7.60% as compared to -32.51% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 221.60 302.77 -26.81 221.60 632.76 -64.98 1367.97 1768.25 -22.64
Other Income 0.27 21.58 -98.75 0.27 21.66 -98.75 95.72 2.39 3905.02
PBIDT -7.60 -32.51 -76.62 -7.60 -35.35 -78.50 -182.39 -1879.36 -90.30
Interest 3.73 118.24 -96.85 3.73 224.38 -98.34 19.04 352.80 -94.60
PBDT -11.33 -150.75 -92.48 -11.33 -259.73 -95.64 -259.72 -2232.16 -88.36
Depreciation 38.62 44.85 -13.89 38.62 89.70 -56.95 184.10 1069.10 -82.78
PBT -49.95 -195.60 -74.46 -49.95 -349.43 -85.71 -443.82 -3301.26 -86.56
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -21.17 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -21.17 0.00
PAT -49.95 -195.60 -74.46 -49.95 -349.43 -85.71 -443.82 -3280.09 -86.47
Equity 165.83 165.83 0.00 165.83 165.83 0.00 165.83 165.83 0.00
PBIDTM(%) -3.43 -10.74 -68.06 -3.43 -5.59 -38.61 -13.33 -106.28 -87.46

Vivimed Labs Share Price

7.79 0.37 (4.99%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×